The US FDA is reviewing the safety of angiotensin receptor blockers (ARBs)

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1311, 2010-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US FDA reviewing safety of orlistat

By  

Reactions Weekly, Vol. 1, Iss. 1267, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Advances in Angiotensin Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 6, 2003-09 ,pp. : 621-631

Bentham Science Publishers

Access to resources Recommend Favorite

US FDA reviewing safety of ezetimibe/simvastatin

By  

Reactions Weekly, Vol. 1, Iss. 1217, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

US FDA reviewing safety of ezetimibe/simvastatin

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

ACE inhibitors and angiotensin receptor blockers (ARBs) appear to be beneficial in patients with acute renal transplant failure

By  

Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite